CooperCompanies Announces First Quarter 2026 Revenue Growth, Updates Guidance
Published on March 6, 2026
SAN RAMON, Calif.—CooperCompanies (Nasdaq: COO), a medical device and contact lens company, yesterday reported its first quarter 2026 financial results for the period ending January 31, 2026. Revenue totaled $1.024 billion, reflecting a 6 percent overall increase and 3 percent organic growth compared with the same period last year. The CooperVision (CVI) business unit contributed $695.1 million, an 8 percent increase year-over-year, with both constant currency and organic growth at 3 percent. The CooperSurgical (CSI) business unit generated $329.0 million, marking a 3 percent increase from the previous year's first quarter, with constant currency and organic growth both reported at 2 percent, the announcement noted.